Intellipharmaceutics International Inc. Annual Interest Expense in USD from 2010 to 2022

Taxonomy & unit
us-gaap: CAD and USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Intellipharmaceutics International Inc. quarterly/annual Interest Expense history and growth rate from 2010 to 2022.
  • Intellipharmaceutics International Inc. Interest Expense for the quarter ending August 31, 2023 was $66.9K, a 26.1% increase year-over-year.
  • Intellipharmaceutics International Inc. Interest Expense for the twelve months ending August 31, 2023 was $234K, a 42.7% decline year-over-year.
  • Intellipharmaceutics International Inc. annual Interest Expense for 2022 was $292K, a 46.9% decline from 2021.
  • Intellipharmaceutics International Inc. annual Interest Expense for 2021 was $549K, a 43.4% decline from 2020.
  • Intellipharmaceutics International Inc. annual Interest Expense for 2020 was $970K, a 292% increase from 2019.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $292K -$258K -46.9% Dec 1, 2021 Nov 30, 2022 20-F/A 2024-02-06
2021 $549K -$420K -43.4% Dec 1, 2020 Nov 30, 2021 20-F/A 2024-02-06
2020 $970K +$722K +292% Dec 1, 2019 Nov 30, 2020 20-F/A 2024-02-06
2019 $248K -$7.72K -3.02% Dec 1, 2018 Nov 30, 2019 20-F/A 2022-05-09
2018 $255K -$134K -34.4% Dec 1, 2017 Nov 30, 2018 20-F 2021-03-31
2017 $389K Dec 1, 2016 Nov 30, 2017 20-F 2020-03-30
2015 $257K -$82.8K -24.4% Dec 1, 2014 Nov 30, 2015 20-F 2016-03-21
2014 $339K +$24.6K +7.8% Dec 1, 2013 Nov 30, 2014 20-F 2016-03-21
2013 $315K +$251K +397% Dec 1, 2012 Nov 30, 2013 20-F 2016-03-21
2012 $63.4K -$20.1K -24% Dec 1, 2011 Nov 30, 2012 20-F 2015-02-27
2011 $83.5K -$15K -15.2% Dec 1, 2010 Nov 30, 2011 20-F 2014-02-18
2010 $98.4K Dec 1, 2009 Nov 30, 2010 20-F/A 2013-02-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.